13D Filing: Starboard Value LP and Depomed Inc (DEPO)

Page 22 of 23

Page 22 of 23 – SEC Filing

SCHEDULE A

Transactions in the Shares Since
the Filing of Amendment No. 8 to the Schedule 13D

Nature of the Transaction

Amount of Shares

Purchased/(Sold)

Price ($)

Date of

Purchase/Sale

 

STARBOARD
VALUE AND OPPORTUNITY MASTER FUND LTD

 

Sale of Common Stock (16,545) 7.0221 03/12/2018
Sale of Common Stock (2,734) 7.0221 03/12/2018
Sale of Common Stock (49,636) 7.1185 03/13/2018
Sale of Common Stock (8,201) 7.1185 03/13/2018
Sale of Common Stock (30,953) 7.2387 03/14/2018
Sale of Common Stock (5,114) 7.2387 03/14/2018
Sale of Common Stock (5,251) 7.2616 03/15/2018
Sale of Common Stock (868) 7.2616 03/15/2018
Sale of May 2018 Call Option ($7 Strike Price) (101,800) 0.4000 04/03/2018
Sale of May 2018 Call Option ($7 Strike Price) (616,400) 0.4000 04/03/2018

 

Starboard
Value and Opportunity S LLC

 

Sale of Common Stock (1,952) 7.0221 03/12/2018
Sale of Common Stock (323) 7.0221 03/12/2018
Sale of Common Stock (5,854) 7.1185 03/13/2018
Sale of Common Stock (970) 7.1185 03/13/2018
Sale of Common Stock (3,651) 7.2387 03/14/2018
Sale of Common Stock (605) 7.2387 03/14/2018
Sale of Common Stock (619) 7.2616 03/15/2018
Sale of Common Stock (103) 7.2616 03/15/2018
Sale of May 2018 Call Option ($7 Strike Price) (12,000) 0.4000 04/03/2018
Sale of May 2018 Call Option ($7 Strike Price) (72,700) 0.4000 04/03/2018

Starboard
Value and Opportunity C LP

 

Sale of Common Stock (1,085) 7.0221 03/12/2018
Sale of Common Stock (178) 7.0221 03/12/2018
Sale of Common Stock (3,256) 7.1185 03/13/2018
Sale of Common Stock (535) 7.1185 03/13/2018
Sale of Common Stock (2,030) 7.2387 03/14/2018
Sale of Common Stock (334) 7.2387 03/14/2018

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 22 of 23